Interaction with alcohol is unknown. Please consult your doctor.
Sporotar 50 mg Injection is probably safe to use during pregnancy. Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Sporotar 50 mg Injection is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Sporotar 50 mg Injection may cause side effects which could affect your ability to drive.
Sporotar 50 mg Injection is safe to use in patients with kidney disease. No dose adjustment of Sporotar 50 mg Injection is recommended. However, inform your doctor if you have any underlying kidney disease.
There is limited information available on the use of Sporotar 50 mg Injection in patients with liver disease. Please consult your doctor.
Liposomal Sporotar is a lipid-associated formulation. Liposomal encapsulation or incorporation into a lipid complex of Sporotar can substantially improves drug safety especially nephrotoxicity associated with the drug
Yes, Sporotar is an antifungal antibiotic for the treatment of serious infections caused by fungi like fungal infections of one or more deep organs of the body, suspected fungal infections in patients with a raised temperature and neutropenia (reduced number of white blood cells [neutrophils]) and Visceral leishmaniasis (disease caused by a parasite)
Yes, administration of Sporotar is associated with allergy (severe and serious allergic) reaction, therefore it is recommended to administer a test dose before starting the therapy to check for sensitivity
Sporotar can disrupt the lipid components of human kidney cells, thereby causing nephrotoxicity. The exact mechanism of hypokalemia is not known, but kidney damage may result in excessive loss of potassium in urine.